Index	Text	Cause	Effect	Offset_Sentence2	Offset_Sentence3	Cause_Start	Cause_End	Effect_Start	Effect_End	Sentence
0433.00035	Due to the relatively low valuations in the healthcare space, namely the drug development companies of AbbVie (NYSE:ABBV), Gilead Sciences (NASDAQ:GILD), and Amgen (NASDAQ:AMGN), I have added to these positions and allowed the dividend income to slightly exceed the 20% limit.	Due to the relatively low valuations in the healthcare space, namely the drug development companies of AbbVie (NYSE:ABBV), Gilead Sciences (NASDAQ:GILD), and Amgen (NASDAQ:AMGN)	I have added to these positions and allowed the dividend income to slightly exceed the 20% limit.			0	177	179	276	<e1>Due to the relatively low valuations in the healthcare space, namely the drug development companies of AbbVie (NYSE:ABBV), Gilead Sciences (NASDAQ:GILD), and Amgen (NASDAQ:AMGN)</e1>, <e2>I have added to these positions and allowed the dividend income to slightly exceed the 20% limit.</e2>
